| More than smell—COVID-19 is associated with severe impairment of smell, taste, and chemesthesis V Parma, K Ohla, MG Veldhuizen, MY Niv, CE Kelly, AJ Bakke, ... Chemical senses 45 (7), 609-622, 2020 | 539 | 2020 |
| Recent smell loss is the best predictor of COVID-19 among individuals with recent respiratory symptoms RC Gerkin, K Ohla, MG Veldhuizen, PV Joseph, CE Kelly, AJ Bakke, ... Chemical senses 46, bjaa081, 2021 | 207* | 2021 |
| Disparities by race and ethnicity among adults recruited for a preclinical Alzheimer disease trial R Raman, YT Quiroz, O Langford, J Choi, M Ritchie, M Baumgartner, ... JAMA Network Open 4 (7), e2114364-e2114364, 2021 | 105 | 2021 |
| Aging well: Using precision to drive down costs and increase health quality R Au, M Ritchie, S Hardy, TFA Ang, H Lin Advances in geriatric medicine and research 1, 2019 | 18 | 2019 |
| GCCR Group Author V Parma, K Ohla, MG Veldhuizen, MY Niv, CE Kelly, AJ Bakke, ... More than just smell-COVID-19 is associated with severe impairment of smell …, 2020 | 15 | 2020 |
| Apolipoprotein E Genetic Testing in a New Age of Alzheimer Disease Clinical Practice M Ritchie, SA Sajjadi, JD Grill Neurology: Clinical Practice 14 (2), e200230, 2024 | 5 | 2024 |
| Recruitment across two decades of NIH-funded Alzheimer’s disease clinical trials M Ritchie, DL Gillen, JD Grill Alzheimer's Research & Therapy 15 (1), 28, 2023 | 5 | 2023 |
| Strategies associated with retaining participants in the longitudinal national Alzheimer’s coordinating center uniform data set study CR Salazar, M Ritchie, DL Gillen, JD Grill Journal of Alzheimer's Disease 87 (4), 1557-1566, 2022 | 5 | 2022 |
| Estimating attrition in mild-to-moderate Alzheimer’s disease and mild cognitive impairment clinical trials M Ritchie, DL Gillen, JD Grill Alzheimer's Research & Therapy 15 (1), 203, 2023 | 3 | 2023 |
| Post‐disclosure distress among racial and ethnic groups in a preclinical AD trial M Ritchie, CR Salazar, DL Gillen, JD Grill Alzheimer's & Dementia 20 (4), 2508-2515, 2024 | 1 | 2024 |
| Effect of Aducanumab Approval on Willingness to Participate in Preclinical Alzheimer’s Disease Trials M Ritchie, M Witbracht, MM Nuño, D Hoang, DL Gillen, JD Grill Journal of Alzheimer's Disease 90 (3), 1291-1300, 2022 | 1 | 2022 |
| Utility of recruitment incentives in early Alzheimer’s disease clinical trials M Ritchie, MG Witbracht, E Russ, SA Sajjadi, G Thai, S Tam, DL Gillen, ... Alzheimer's Association International Conference, 2024 | | 2024 |
| Impact of Study Partner Type on Participant Retention Across Global Regions in the Tauriel and Lauriet Trials for Alzheimer’s Disease M Ritchie, S Datta, C Monteiro, B Toth, E Teng Alzheimer's Association International Conference, 2024 | | 2024 |
| Deriving meaningful within-patient change thresholds for the ADCS-ADL in trials of early and mild-to-moderate Alzheimer’s disease-a caregiver-rated, anchor-based analysis of … M Ritchie, S Datta, CJ Lansdall, C Monteiro, B Toth, E Teng Alzheimer's Association International Conference, 2024 | | 2024 |
| Experiences recruiting from neighborhoods based on area deprivation index (ADI) E Russ, AJH Kind, DL Gillen, MG Witbracht, M Ritchie, E Duran, ... Alzheimer's Association International Conference, 2024 | | 2024 |
| The utility of recruitment incentives in early Alzheimer's disease trials M Ritchie, M Witbracht, E Russ, SA Sajjadi, GT Thai, S Tam, DL Gillen, ... Alzheimer's & Dementia, 2024 | | 2024 |
| Views and perceptions of amyloid imaging in a preclinical Alzheimer’s disease trial M Ritchie, R Raman, K Ernstrom, S Wang, MC Donohue, PSS Aisen, ... Alzheimer's & Dementia 19, e080576, 2023 | | 2023 |
| Intrusive thoughts and distress following amyloid status disclosure in a preclinical Alzheimer’s disease trial: Comparisons across racial and ethnic groups M Ritchie, DL Gillen, J Grill Alzheimer's & Dementia 18, e063973, 2022 | | 2022 |
| Estimating attrition in mild‐to‐moderate Alzheimer’s disease and mild cognitive impairment clinical trials M Ritchie, DL Gillen, JD Grill Alzheimer's & Dementia 17, e053051, 2021 | | 2021 |
| Effectiveness of 2nd Skull Products in Reducing Head Impact in Simulated Sports M Ritchie, H Lin, R Au medRxiv, 2020.05. 05.20092569, 2020 | | 2020 |
Joshua GrillUC IrvineVerified email at uci.edu
